What is remission?

How have treatments for acute myeloid leukemia evolved over the years?
What are some of the major side effects of treatment that patients should be prepared for?
If we are able to identify and target someone's AML genetics, why is AML still difficult to get rid of?
What are the gene mutations that we currently have targeted drugs for?
Which gene mutations are categorized as low, intermediate and high risk AML?
What are cytogenetics and what does it tell us about someone's AML?
What does the term genetics mean, and why is it relevant to patients with AML?
(Guest Lecture) Syed Abbas Ali Presents Case Studies: Discussion with Morning Faculty | RT Austin, TX Mar 25, 2023 -
(Guest Lecture) Putting Your Disease Into Your Context - William Matsui, MD | RT Austin, TX Mar 25, 2023
(Guest Lecture) So Many Choices: Deciding Which Treatment is Best - Matthew Butler, MD | RT Austin, TX Mar 25, 2023
What is FLT3 positive AML? What is gilteritinib?
When during a course of treatment is gilteritinib used to treat FLT3 positive AML?
What research is being done with gliteritinib to make this therapy more effective?
How do you find out what CD markers are on a cell?